Federation Des Caisses Desjardins Du Quebec Precision Biosciences Inc Transaction History

Federation Des Caisses Desjardins Du Quebec

$18.9 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Aug 14, 2024	BUY	$0.34 - $0.69 $30 - $62	90 Added 24.66%	455 $155,000
Q1 2022 Aug 14, 2024	BUY	$2.96 - $7.76 $1,080 - $2,832	365 New	365 $1.12 Million
Q2 2021 Aug 30, 2024	BUY	$8.07 - $12.52 $2,945 - $4,569	365 New	365 $4.57 Million
Q1 2021 Aug 30, 2024	BUY	$8.57 - $15.79 $3,128 - $5,763	365 New	365 $3.78 Million

Others Institutions Holding DTIL

# of Institutions

Shares Held

2.56M

Call Options Held

Put Options Held

Oup Management Co., LLC

1.12M
Shares

$5.62 Million
0.86% of portfolio
Chi Advisors LLC New York, NY

607K
Shares

$3.03 Million
0.1% of portfolio
Jacob Asset Management Of New York LLC Hermosa Beach, CA

390K
Shares

$1.95 Million
0.19% of portfolio
Tekla Capital Management LLC

225K
Shares

$1.12 Million
0.0% of portfolio
Vericrest Private Wealth Newtown, PA

155K
Shares

$773,470
0.3% of portfolio

View Full List

About PRECISION BIOSCIENCES INC

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $554M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

More about DTIL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Account